Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: IMO Schwartz stock sales may be the key that unravels this conundrum

Excellent point.

If we can find out what triggered an inqiry to EDIG at the end of February and reproduce it, I think we can get a lot more visibility.

I am unable to copy and paste but please see Agora edig board by Greengo May 2 4:16 pm and Ofarmer May 6 10:36 am.

Edig's 10q was questioned by SEC and made them produce a 5 page answer that was most revealing.



TK

Share
New Message
Please login to post a reply